GSK's new RSV campaign lands in advance of FDA decision set for next week
A week before the FDA is expected to decide whether to approve GlaxoSmithKline’s vaccine for respiratory syncytial virus, the pharma giant has a message for seniors: Don’t get “cut short” by RSV.
In a new TV ad, GSK outlines the heightened risks of the virus for older adults and those with pre-existing conditions like asthma or COPD. This includes severe infections that may lead to hospitalization. The video depicts seniors wandering around an art museum, volunteering and playing pickleball before they’re abruptly interrupted by a black screen.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
